Loading CHGCY…
Loading profile data…Frequently asked questions about CHGCY
What does Chugai Pharmaceutical Co., Ltd. (CHGCY) do?
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perj
Where does CHGCY trade?
Chugai Pharmaceutical Co., Ltd. (CHGCY) trades on the Other OTC.
What sector is CHGCY in?
Chugai Pharmaceutical Co., Ltd. (CHGCY) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Chugai Pharmaceutical Co., Ltd.?
Osamu Okuda is the chief executive officer of Chugai Pharmaceutical Co., Ltd. (CHGCY).
Where is Chugai Pharmaceutical Co., Ltd. headquartered?
Chugai Pharmaceutical Co., Ltd. is headquartered in Japan.
When did CHGCY go public?
Chugai Pharmaceutical Co., Ltd. (CHGCY) completed its initial public offering in 2012.
Is CHGCY an ADR?
Yes — CHGCY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Chugai Pharmaceutical Co., Ltd. reporting and dividends follow the underlying issuer.